We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,266 hedge funds and large institutions have $176B invested in Thermo Fisher Scientific in 2022 Q3 according to their latest regulatory filings, with 116 funds opening new positions, 927 increasing their positions, 863 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 116 | Existing positions closed: 102

13% more call options, than puts

Call options by funds: $1.47B | Put options by funds: $1.3B

7% more repeat investments, than reductions

Existing positions increased: 927 | Existing positions reduced: 863

0.97% more ownership

Funds ownership: 87.64%88.62% (+0.97%)

1% less funds holding

Funds holding: 2,2812,266 (-15)

5% less capital invested

Capital invested by funds: $186B → $176B (-$9.79B)

6% less funds holding in top 10

Funds holding in top 10: 253238 (-15)

Holders
2,266
Holders Change
-15
Holders Change %
-0.66%
% of All Funds
39.04%
Holding in Top 10
238
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-5.93%
% of All Funds
4.1%
New
116
Increased
927
Reduced
863
Closed
102
Calls
$1.47B
Puts
$1.3B
Net Calls
+$166M
Net Calls Change
+$177M
Name Holding Trade Value Shares
Change
Change in
Stake
SIM
1251
Sentry Investment Management
Wisconsin
$1.42M +$83.9K +150 +6%
CAM
1252
Covenant Asset Management
New Jersey
$1.42M
CCM
1253
Cullen Capital Management
New York
$1.42M +$21.8K +39 +1%
OC
1254
Oakworth Capital
Alabama
$1.42M +$141K +252 +10%
SS
1255
Sunbelt Securities
Texas
$1.42M +$26.3K +47 +2%
ECM
1256
Evergreen Capital Management
Washington
$1.42M +$237K +424 +18%
CT
1257
Chicago Trust
Illinois
$1.41M -$36.4K -65 -2%
MLA
1258
My Legacy Advisors
Oregon
$1.41M +$69.4K +124 +5%
MFA
1259
Mayflower Financial Advisors
Massachusetts
$1.4M -$168K -301 -10%
EWS
1260
Evergreen Wealth Solutions
Pennsylvania
$1.4M +$167K +299 +12%
Voloridge Investment Management
1261
Voloridge Investment Management
Florida
$1.4M +$1.55M +2,765 New
SXL
1262
Summit X LLC
Missouri
$1.4M +$39.7K +71 +3%
ANTB
1263
AMG National Trust Bank
Colorado
$1.4M +$117K +209 +8%
AA
1264
AlphaMark Advisors
Kentucky
$1.39M -$3.92K -7 -0.3%
MFG
1265
Magnus Financial Group
New York
$1.38M +$2.8K +5 +0.2%
IIM
1266
Intact Investment Management
Quebec, Canada
$1.37M -$56K -100 -4%
CMANY
1267
Capital Management Associates (New York)
New York
$1.37M
Grantham, Mayo, Van Otterloo & Co (GMO)
1268
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$1.37M +$1.51M +2,700 New
Verition Fund Management
1269
Verition Fund Management
Connecticut
$1.37M +$561K +1,003 +59%
HWA
1270
Heritage Wealth Advisors
Virginia
$1.37M +$353K +631 +31%
ECA
1271
Elevated Capital Advisors
Utah
$1.36M +$1.5M +2,682 New
SW
1272
SlateStone Wealth
Florida
$1.35M +$158K +282 +12%
ACIM
1273
Azimuth Capital Investment Management
Michigan
$1.35M -$2.8K -5 -0.2%
EWA
1274
EverSource Wealth Advisors
Alabama
$1.34M +$1.09M +1,943 +277%
RIA
1275
Regal Investment Advisors
Michigan
$1.34M -$2.8K -5 -0.2%

TMO Hedge Fund Activity: Q3 2022 in Review

2,266 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2022, worth a combined $176B — down 5.3% from $186B a quarter earlier.

Buyers outnumbered sellers: 116 funds opened new TMO positions and 102 closed out — a net gain of 14 holders — while 927 added to existing stakes and 863 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $795M. The largest seller was T. Rowe Price Associates, cutting an estimated $2.12B.

  • 2,266 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2022, down from 2,281 in Q2 2022.
  • Funds reported $176B of Thermo Fisher Scientific stock for Q3 2022, down 5.3% quarter-over-quarter.
  • 116 funds opened new Thermo Fisher Scientific positions in Q3 2022 and 102 closed out, a net change of +14 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2022 was Janus Henderson Group, an estimated $795M added.
  • The largest Thermo Fisher Scientific seller in Q3 2022 was T. Rowe Price Associates, an estimated $2.12B sold.

Based on aggregated 13F filings for Q3 2022.